| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ... Gastroenterology 124 (4), 961-971, 2003 | 285 | 2003 |
| Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ... Journal of molecular medicine 80, 16-24, 2002 | 204 | 2002 |
| VIP–PACAP system in immunity: new insights for multitarget therapy RP Gomariz, Y Juarranz, C ABAD, A Arranz, J Leceta, C Martinez Annals of the New York Academy of Sciences 1070 (1), 51-74, 2006 | 158 | 2006 |
| Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ... Arthritis research & therapy 7, 1-12, 2005 | 158 | 2005 |
| PACAP in immunity and inflammation M Delgado, C Abad, C Martinez, MG Juarranz, J Leceta, D Ganea, ... Annals of the New York Academy of Sciences 992 (1), 141-157, 2003 | 152 | 2003 |
| Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor C Martinez, C Abad, M Delgado, A Arranz, MG Juarranz, ... Proceedings of the National Academy of Sciences 99 (2), 1053-1058, 2002 | 151 | 2002 |
| The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases EM García-Cuesta, CA Santiago, J Vallejo-Díaz, Y Juarranz, ... Frontiers in Endocrinology 10, 479052, 2019 | 142 | 2019 |
| VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts I Gutierrez-Canas, Y Juarranz, B Santiago, A Arranz, C Martinez, ... Rheumatology 45 (5), 527-532, 2006 | 105 | 2006 |
| Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP RP Gomariz, A Arranz, C Abad, M Torroba, C Martinez, F Rosignoli, ... Journal of leukocyte biology 78 (2), 491-502, 2005 | 104 | 2005 |
| Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells MG Juarranz, B Santiago, M Torroba, I Gutierrez-Canas, G Palao, ... Rheumatology 43 (4), 416-422, 2004 | 103 | 2004 |
| IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts M Carrion, Y Juarranz, C Martínez, I Gonzalez-Alvaro, JL Pablos, ... Rheumatology 52 (12), 2177-2186, 2013 | 90 | 2013 |
| Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts Y Juarranz, I Gutiérrez‐Cañas, B Santiago, M Carrión, JL Pablos, ... Arthritis & Rheumatism 58 (4), 1086-1095, 2008 | 86 | 2008 |
| Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction RM Solano, I Langer, J Perret, P Vertongen, MG Juarranz, P Robberecht, ... Journal of Biological Chemistry 276 (2), 1084-1088, 2001 | 85 | 2001 |
| cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP C Abad, Y Juarranz, C Martinez, A Arranz, F Rosignoli, M García-Gómez, ... Inflammatory bowel diseases 11 (7), 674-684, 2005 | 83 | 2005 |
| RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide M Carrión, Y Juarranz, S Pérez‐García, R Jimeno, JL Pablos, RP Gomariz, ... Arthritis & Rheumatism 63 (6), 1626-1636, 2011 | 79 | 2011 |
| VIP and PACAP are autocrine factors that protect the androgen‐independent prostate cancer cell line PC‐3 from apoptosis induced by serum withdrawal I Gutiérrez‐Cañas, N Rodríguez‐Henche, O Bolaños, MJ Carmena, ... British journal of pharmacology 139 (5), 1050-1058, 2003 | 71 | 2003 |
| Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis C Martínez, AM Ortiz, Y Juarranz, A Lamana, IV Seoane, J Leceta, ... PloS one 9 (1), e85248, 2014 | 68 | 2014 |
| Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation J Leceta, RP Gomariz, C Martinez, M Carrión, A Arranz, Y Juarranz Neuroimmunomodulation 14 (3-4), 134-138, 2007 | 68 | 2007 |
| New insights into the role of VIP on the ratio of T‐cell subsets during the development of autoimmune diabetes R Jimeno, RP Gomariz, I Gutiérrez‐Cañas, C Martínez, Y Juarranz, ... Immunology and cell biology 88 (7), 734-745, 2010 | 63 | 2010 |
| Pituitary adenylate-cyclase-activating polypeptide expression in the immune system C Abad, C Martinez, J Leceta, MG Juarranz, M Delgado, RP Gomariz Neuroimmunomodulation 10 (3), 177-186, 2002 | 60 | 2002 |
Rosa P. GomarizCatedratica de Biología CelularE-mail megerősítve itt: bio.ucm.es
